Sort
11,323 grants matching “glioblastoma”
Project 3: Inhibition of radiation-induced phenotype conversion in glioblastoma
$345,840Frank Pajonk · University Of California Los Angeles · P50 · FY2019 · CA
Project 1: Active immunotherapy combined with checkpoint modulation for glioblastoma
$345,824Robert M Prins · University Of California Los Angeles · P50 · FY2019 · CA
Project 1: Active immunotherapy combined with checkpoint modulation for glioblastoma
$345,823Linda M Liau · University Of California Los Angeles · P50 · FY2021 · CA
Role of mTORC2 in GBM - development of a novel therapeutic mTOR kinase inhibitor
$345,736Paul S Mischel · Ludwig Institute For Cancer Res Ltd · R01 · FY2014 · NS
Genotypic Interactions in Brain Cancer Heterogeneity
$345,625Frank Furnari · University Of California, San Diego · R01 · FY2022 · NS
SLFN5: A Novel Therapeutic Target for Glioblastoma
$345,625Leonidas C Platanias · Northwestern University At Chicago · R01 · FY2020 · NS
Role of purine metabolism in chemoresistance
$345,625Atique U. Ahmed · Northwestern University At Chicago · R01 · FY2021 · NS
SLFN5: A Novel Therapeutic Target for Glioblastoma
$345,625Leonidas C Platanias · Northwestern University At Chicago · R01 · FY2019 · NS
Role of purine metabolism in chemoresistance
$345,625Atique U. Ahmed · Northwestern University At Chicago · R01 · FY2023 · NS
Role of TEMs in brain tumor dispersal
$345,625Candelaria Gomez-Manzano · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · NS
Role of purine metabolism in chemoresistance
$345,625Atique U. Ahmed · Northwestern University At Chicago · R01 · FY2022 · NS
SLFN5: A Novel Therapeutic Target for Glioblastoma
$345,625Leonidas C Platanias · Northwestern University At Chicago · R01 · FY2022 · NS
A Phase 2 study of AZD2171 in Recurrent Glioblastoma
$345,625Massachusetts General Hospital · R21 · FY2005 · CA
SLFN5: A Novel Therapeutic Target for Glioblastoma
$345,625Leonidas C Platanias · Northwestern University At Chicago · R01 · FY2023 · NS
SLFN5: A Novel Therapeutic Target for Glioblastoma
$345,625Leonidas C Platanias · Northwestern University At Chicago · R01 · FY2021 · NS
Role of purine metabolism in chemoresistance
$345,625Atique U. Ahmed · Northwestern University At Chicago · R01 · FY2020 · NS
Role of purine metabolism in chemoresistance
$345,625Atique U. Ahmed · Northwestern University At Chicago · R01 · FY2019 · NS
Engineer Biomimetic Microfluidic Models to Investigate and Reprogram Tumor Associated Neutrophils for Cancer Therapy
$345,548Xiaoping Bao · Purdue University · R37 · FY2023 · CA
Combining Anti-Invasive and Anti-Angiogenic Therapies for the treatment of GBM
$345,494Panagiotis Z Anastasiadis · Mayo Clinic Jacksonville · R01 · FY2010 · NS
LuIII parvovirus targets glioma
$345,488Anthony N Van Den Pol · Yale University · R01 · FY2015 · CA
Project 4- Targeting the neuronal microenvironment in gliomas (Monje/Suva)
$345,439Mario Luca Suva · Brigham And Women'S Hospital · P50 · FY2023 · CA
Project 4- Targeting the neuronal microenvironment in gliomas (Monje/Suva)
$345,439Mario Luca Suva · Brigham And Women'S Hospital · P50 · FY2022 · CA
Project 2: Sexual Dimorphism of Iron Metabolism in GBM
$345,280James R Connor · Cleveland Clinic Lerner Com-Cwru · P01 · FY2024 · CA
INDIVIDUALIZING IMRT TREATMENT IN BRAIN AND HEAD/NECK CA
$345,259Avraham Eisbruch · University Of Michigan At Ann Arbor · P01 · FY2010 · CA
LuIII parvovirus targets glioma
$345,229Anthony N Van Den Pol · Yale University · R01 · FY2013 · CA